arrow
Back
W

William G. Wierda

MD Anderson Cancer Center

121H-index
1.5KPaper Count
6.2WCitation Count
Published Papers 246
Publication Date
Unfinished Business in Chronic Lymphocytic Leukemia: Translational and Clinical Priorities for a Cure
errBlood
IF23.1
err2026-04-25
err0
errOAAI
errCatherine J Wu; Federico Caligaris-Cappio; Nicholas Chiorazzi; John G Gribben; Michael Hallek; William G. Wierda; Thomas J Kipps
errShare
errSave
Final phase 2 study results of acalabrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia
err2026-04-02
err0
errOAAI
errRichard R. Furman; William G. Wierda; Piers E.M. Patten; Jorge M. Chaves; Jennifer R. Brown; Talha Munir; Peter Martin; Farrukh T. Awan; Deborah M. Stephens; Paolo Ghia; Jacqueline C. Barrientos; Krish Patel; Jennifer A. Woyach; Marianne de Borja; Min-Hui Wang; Nitin Jain; Susan M. O’Brien; John C. Byrd
errShare
errSave
NGS-based measurable residual disease in long-term progression-free CLL survivors following FCR therapy
err2026-03-27
err0
errOAAI
errAlexandre Bazinet; Alessandra Ferrajoli; Nitin Jain; Jan Burger; Musa Yilmaz; Mahesh Swaminathan; Hagop Kantarjian; Michael Keating; Philip A. Thompson; William G. Wierda
errShare
errSave
The Care and Cure of the Leukemias in 2026
err2026-02-27
err0
PREAI
errHagop Kantarjian; Helen T. Chifotides; Fadi G. Haddad; Elias Jabbour; Nitin Jain; Tapan Kadia; Farhad Ravandi; Mary Alma Welch; William Wierda; Emil J. Freireich
errShare
errSave
Mutational Landscape and Clinical Impact of SPEN Mutations in Patients with Chronic Lymphocytic Leukemia
err2025-11-06
err0
errOAAI
errPriyatharsini Nirmalanantham; Andrés E. Quesada; Anindita Ghosh; Pei Lin; Chi Y. Ok; Richard K. Yang; Hong Fang; Sofia Garces; Rashmi Kanagal-Shamanna; Sanam Loghavi; Mark J. Routbort; Cameron Cheng Yin; Wang Wei; Sarah Pasyar; Roland Bassett; Siba El Hussein; Nitin Jain; Jan Burger; William G. Wierda; Sa Wang; Carlos Bueso-Ramos; Keyur P. Patel; Leonard Jeffrey Medeiros; Fatima Zahra Jelloul
errShare
errSave
Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression
err2025-10-27
err0
errOAAI
errShady I. Tantawy; Burcu Aslan; Ganiraju Manyam; LaKesla R. Iles; Natalia Timofeeva; Neetu Singh; Nitin Jain; Alessandra Ferrajoli; Philip A. Thompson; Keyur P. Patel; Sai Prasad Desikan; William G. Wierda; Varsha Gandhi
errShare
errSave
Hitting the therapeutic bull’s-eye with targeted therapy for patients with chronic lymphocytic leukemia
errBlood
IF23.1
err2025-06-04
err0
PREAI
errWilliam G. Wierda; Barbara Eichhorst; Michael Hallek
errShare
errSave
Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN
errBlood
IF23.1
err2025-04-11
err0
errOAAI
errJeff P. Sharman; Miklos Egyed; Wojciech Jurczak; Alan Skarbnik; Krish Patel; Ian W. Flinn; Manali Kamdar; Talha Munir; Renata Walewska; Marie Hughes; Laura Maria Fogliatto; Yair Herishanu; Versha Banerji; George Follows; Patricia Walker; Paolo Ghia; Ann Janssens; John C. Byrd; Emmanuelle Ferrant; Alessandra Ferrajoli; William G. Wierda; Catherine Wangui Wachira; Batul T. Suterwala; Paulo Miranda; Veerendra Munugalavadla; Chuan-Chuan Wun; Jennifer A. Woyach
errShare
errSave
Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3
errLEUKEMIA
IF13.4
err2025-03-19
err1
errOAAI
errShah, Bijal D.; Cassaday, Ryan D.; Park, Jae H.; Houot, Roch; Logan, Aaron C.; Boissel, Nicolas; Leguay, Thibaut; Bishop, Michael R.; Topp, Max S.; O'Dwyer, Kristen M.; Tzachanis, Dimitrios; Arellano, Martha L.; Lin, Yi; Baer, Maria R.; Schiller, Gary J.; Subklewe, Marion; Abedi, Mehrdad; Minnema, Monique C.; Wierda, William G.; Deangelo, Daniel J.; Stiff, Patrick; Jeyakumar, Deepa; Mao, Daqin; Adhikary, Sabina; Zhou, Lang; Hadjivassileva, Tsveta; Khalid, Rita Damico; Ghobadi, Armin; Oluwole, Olalekan O.
errShare
errSave
Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naive chronic lymphocytic leukemia (Dec, 10.1038/s41375-024-02487-1, 2024)
errLEUKEMIA
IF13.4
err2024-12-03
err0
errOAAI
errSharman, Jeff P.; Egyed, Miklos; Jurczak, Wojciech; Skarbnik, Alan; Pagel, John M.; Flinn, Ian W.; Kamdar, Manali; Munir, Talha; Walewska, Renata; Corbett, Gillian; Fogliatto, Laura Maria; Herishanu, Yair; Banerji, Versha; Coutre, Steven; Follows, George; Walker, Patricia; Karlsson, Karin; Ghia, Paolo; Janssens, Ann; Cymbalista, Florence; Woyach, Jennifer A.; Ferrant, Emmanuelle; Wierda, William G.; Munugalavadla, Veerendra; Yu, Ting; Wang, Min Hui; Byrd, John C.
errShare
errSave
Protein Degrader WH25244 Eliminates Venetoclax Resistance Factors: Mutant or Hyperphosphorylated BCL2, and BCL-XL
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errRohena, Daisy Y. Diaz; Mitchell, Andrew D.; Wang, Jing; Chamberlain, Stephanie; Liu, Chaomei; Sanchez II, John R.; Williams, Charmelle D.; Wathan, Trisha K.; Slawin, Bailey; Bowman, Kevin; Yuan, Yaxia; Zhang, Peiyi; Hu, Wanyi; Zheng, Guangrong; Wierda, William G.; Jain, Nitin; Davids, Matthew S.; Zhou, Daohong; Woyach, Jennifer A.; Sampath, Deepa
errShare
errSave
Comprehensive Characterization of Inflammatory Cytokines in Chronic Lymphocytic Leukemia Highlight Immune Dysregulation and Associates with MRD
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errWang, Bofei; Root, Jessica Lynn; Garza, Araceli Isabella; Breaker, Joyce; Wierda, William G.; Abbas, Hussein A.; Reville, Patrick K.
errShare
errSave
Management of HCV-Infection in Pediatric Patients Undergoing HCT: A Single-Center Experience
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errPagano, Gennaro; Rossitti, Emanuela; Cacace, Fabiana; Caprioli, Valeria; D'Amico, Maria Rosaria; De Simone, Giuseppina; Sabbatino, Maria Simona; Wierda, William G.; Tambaro, Francesco Paolo Paolo
errShare
errSave
The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemia
err2024-10-23
err0
errOAAI
errZhang, Ronghua; Khare, Priyanka; Banerjee, Priyanka; Ivan, Cristina; Schneider, Sarah; Barbaglio, Federica; Clise-Dwyer, Karen; Jensen, Vanessa Behrana; Thompson, Erika; Mendoza, Marisela; Chiorazzi, Nicholas; Chen, Shih-Shih; Yan, Xiao-Jie Joy; Jain, Nitin; Ghia, Paolo; Caligaris-Cappio, Federico; Mendonsa, Rima; Kasimsetty, Sashi; Swoboda, Ryan; Bayraktar, Recep; Wierda, William; Gandhi, Varsha; Calin, George A.; Keating, Michael J.; Bertilaccio, Maria Teresa Sabrina
errShare
errSave
Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial
err2024-10-03
err2
errOAAI
errShah, Nirav N.; Wang, Michael; Roeker, Lindsey E.; Patel, Krish; Woyach, Jennifer A.; Wierda, William G.; Ujjani, Chaitra S.; Eyre, Toby A.; Zinzani, Pier Luigi; Alencar, Alvaro J.; Ghia, Paolo; Lamanna, Nicole; Hoffmann, Marc S.; Patel, Manish R.; Flinn, Ian; Gerson, James N.; Ma, Shuo; Coombs, Catherine C.; Cheah, Chan Y.; Lech-Maranda, Ewa; Fakhri, Bita; Kim, Won Seog; Barve, Minal A.; Cohen, Jonathon B.; Jurczak, Wojciech; Munir, Talha; Thompson, Meghan C.; Tsai, Donald E.; Bao, Katherine; Cangemi, Nicholas A.; Kherani, Jennifer F.; Walgren, Richard A.; Han, Hongmei; Ruppert, Amy S.; Brown, Jennifer R.
errShare
errSave
Longitudinal follow up of a phase 2 trial of venetoclax added to hyper-CVAD, nelarabine and pegylated asparaginase in patients with T-cell acute lymphoblastic leukemia and lymphoma
errLEUKEMIA
IF13.4
err2024-09-25
err0
PREAI
errRavandi, Farhad; Senapati, Jayastu; Jain, Nitin; Short, Nicholas J.; Kadia, Tapan; Borthakur, Gautam; Konopleva, Marina; Wierda, William; Huang, Xuelin; Maiti, Abhishek; Issa, Ghayas; Balkin, Hayley; Garris, Rebecca; Ferrajoli, Alessandra; Garcia-Manero, Guillermo; Alvarado, Yesid; Kebriaei, Partow; Jabbour, Elias; Kantarjian, Hagop M.
errShare
errSave
Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN study
err2024-09-01
err2
PREAI
errWierda, William G.; Shah, Nirav N.; Cheah, Chan Y.; Lewis, David; Hoffmann, Marc S.; Coombs, Catherine C.; Lamanna, Nicole; Ma, Shuo; Jagadeesh, Deepa; Munir, Talha; Wang, Yucai; Eyre, Toby A.; Rhodes, Joanna M.; McKinney, Matthew; Lech-Maranda, Ewa; Tam, Constantine S.; Jurczak, Wojciech; Izutsu, Koji; Alencar, Alvaro J.; Patel, Manish R.; Seymour, John F.; Woyach, Jennifer A.; Thompson, Philip A.; Abada, Paolo B.; Ho, Caleb; McNeely, Samuel C.; Marella, Narasimha; Nguyen, Bastien; Wang, Chunxiao; Ruppert, Amy S.; Nair, Binoj; Liu, Hui; Tsai, Donald E.; Roeker, Lindsey E.; Ghia, Paolo
errShare
errSave
Transcriptomic and proteomic differences in BTK-WT and BTK-mutated CLL and their changes during therapy with pirtobrutinib
err2024-08-28
err0
errOAAI
errAslan, Burcu; Manyam, Ganiraju; Iles, Lakesla R.; Tantawy, Shady I.; Desikan, Sai Prasad; Wierda, William G.; Gandhi, Varsha
errShare
errSave
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia
err2024-05-17
err3
errOAAI
errHampel, Paul J.; Swaminathan, Mahesh; Rogers, Kerry A.; Parry, Erin M.; Burger, Jan A.; Davids, Matthew S.; Ding, Wei; Ferrajoli, Alessandra; Hyak, Jonathan M.; Jain, Nitin; Kenderian, Saad S.; Wang, Yucai; Wierda, William G.; Woyach, Jennifer A.; Parikh, Sameer A.; Thompson, Philip A.
errShare
errSave
Single-cell proteogenomics analysis of AML samples treated with decitabine and venetoclax reveals divergent treatment escape mechanisms
err2024-03-22
err0
PREAI
errKim, Yi June; Li, Zongrui; Maiti, Abhishek; Tanaka, Tomoyuki; Uryu, Hidetaka; Furudate, Ken; Hayes, Kala; Daver, Naval; Pemmaraju, Naveen; Kadia, Tapan M.; Ravandi, Farhad; Short, Nicholas J.; Ohanian, Maro; Borthakur, Gautam; Jain, Nitin; Issa, Ghayas C.; Masarova, Lucia; Kornblau, Steven M.; Wierda, William G.; Loghavi, Sanam; Wang, Sa A.; Garcia-Manero, Guillermo; Kantarjian, Hagop; DiNardo, Courtney D.; Konopleva, Marina Y.; Takahashi, Koichi
errShare
errSave